Steroid treatment in the management of destructive thyrotoxicosis induced by PD1 blockade
In this medfyle
Steroids likely beneficial in improving levels of thyroid hormones in patients with destructive thyrotoxicosis related to PD-1 inhibition.
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Expert commentary
About this Medfyle
This is a highlights summary of an oral session given at the ENDO 2022 Annual Conference and presented by:
Alessandro Brancatella, MD
University of Pisa
Pisa, Italy
The content is produced by Infomedica, the official reporting partner of ENDO 2022.
The presenting authors of the original session had no part in the creation of this conference highlights summary.
In addition, an expert commentary on the topic has been provided by:
Eyal Robenshtok, MD
Endocrinology & Metabolism institute
Rabin Medical Center and Tel-Aviv University, Israel
